SG Americas Securities
CTMX icon

SG Americas Securities’s CytomX Therapeutics CTMX Stock Holding History

SG Americas Securities’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
+36,863
New +$141K ﹤0.01% 2959
2026
Q1 		– Sell
-53,109
Closed -$226K – 3335
2025
Q4 		$226K Buy
+53,109
New +$202K ﹤0.01% 2878
2024
Q2 		– Sell
-26,114
Closed -$57K – 2937
2024
Q1 		$57K Buy
+26,114
New +$48.2K ﹤0.01% 2723
2022
Q2 		– Sell
-14,530
Closed -$39K – 3446
2022
Q1 		$39K Buy
14,530
+4,321
+42% +$16.6K ﹤0.01% 2857
2021
Q4 		$44K Sell
10,209
-20,637
-67% -$121K ﹤0.01% 3205
2021
Q3 		$157K Buy
30,846
+19,272
+167% +$103K ﹤0.01% 3395
2021
Q2 		$73K Sell
11,574
-1,902
-14% -$14.8K ﹤0.01% 2713
2021
Q1 		$104K Buy
+13,476
New +$107K ﹤0.01% 3064
2020
Q4 		– Sell
-21,797
Closed -$145K – 3354
2020
Q3 		$145K Buy
21,797
+9,699
+80% +$71.9K ﹤0.01% 2295
2020
Q2 		$101K Sell
12,098
-5,257
-30% -$48.8K ﹤0.01% 3363
2020
Q1 		$133K Buy
+17,355
New +$121K ﹤0.01% 2787
2018
Q3 		– Sell
-5,200
Closed -$119K – 3192
2018
Q2 		$119K Buy
+5,200
New +$133K ﹤0.01% 2963
2016
Q4 		– Sell
-7,478
Closed -$117K – 3169
2016
Q3 		$117K Buy
+7,478
New +$90.5K ﹤0.01% 2938

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

SG Americas Securities's CTMX Position: Q2 2026 in Review

SG Americas Securities opened a new position in CytomX Therapeutics (CTMX) in Q2 2026: 36,863 shares worth $138K. The stake represents ﹤0.01% of the portfolio and ranks #2959 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in CTMX as recently as Q4 2025.

SG Americas Securities first reported a position in CTMX in Q3 2016 and has held it in 13 quarters since. The position peaked at $226K in Q4 2025. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • SG Americas Securities held 36,863 shares of CytomX Therapeutics worth $138K as of Q2 2026.
  • CytomX Therapeutics was a new SG Americas Securities position in Q2 2026.
  • CytomX Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2959 holding.
  • SG Americas Securities first reported a position in CytomX Therapeutics in Q3 2016 and has held it in 13 quarters since.
  • SG Americas Securities's CytomX Therapeutics position peaked at $226K in Q4 2025.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.